Successful treatment of an infant with CDA type II by intrauterine transfusions and postnatal stem cell...

Area of Science:

• Hematology
• Genetics
• Pediatrics

Background:

• Congenital dyserythropoietic anemias (CDAs) are rare genetic disorders characterized by ineffective erythropoiesis and chronic anemia.
• Patients often develop iron overload as a complication of ineffective red blood cell production and necessary transfusions.

Observation:

• This report details a severe case of CDA type II presenting as fetal hydrops in an infant.
• The infant required intrauterine and continued postnatal red blood cell transfusions.

Findings:

• The patient underwent successful allogeneic hematopoietic stem cell transplantation (HSCT) using a myeloablative conditioning regimen.
• Peripheral blood stem cells from a matched donor were utilized for the transplantation.

Implications:

• Allogeneic HSCT is a potential therapeutic option for infants with severe CDA type II.
• This approach may be effective even when only a matched unrelated donor is available, expanding treatment possibilities.